Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00840749 · ClinicalTrials.gov registry record · NA
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
A NA study, sponsored by Accuray Incorporated.
- Terminated
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00840749 is a NA study that was terminated before completion, run by Accuray Incorporated. The registered enrollment target is 36 participants.
The verdict
NCT00840749, a NA study, was terminated before completion, sponsored by Accuray Incorporated.
- TERMINATED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Lung cancer remains the most frequent cause of cancer death in both men and women in the world. Surgical resection using lobectomy with mediastinal lymph node dissection or sampling has been a standard of care for operable early stage NSCLC. Several studies have reported high local control and survival using SBRT in stage I NSCLC patients. SBRT is now an accepted treatment for medically inoperable patients with stage I NSCLC and patients with operable stage I lung cancer are entered on clinical protocols. The purpose of this study is to conduct a phase III randomized study to compare CyberKnife SBRT with surgery, the current standard of care for stage I operable NSCLC.
Interventions
- PROCEDURE Surgery
- RADIATION CyberKnife Stereotactic Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00840749
The ClinicalTrials.gov registry entry for NCT00840749 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Accuray Incorporated, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Surgery is the first listed.
NCT00840749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00840749 about?
NCT00840749 is a clinical study titled "Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer". Lung cancer remains the most frequent cause of cancer death in both men and women in the world. Surgical resection using lobectomy with mediastinal lymph node dissection or sampling has been a standard of care for operable early stage NSCLC. Several studies have reported high local control and survi...
What is the current status of trial NCT00840749?
This trial is currently terminated. It is a NA study. The enrollment target is 36 participants. The study started on 2008-12. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00840749?
The interventions under investigation include: Surgery (PROCEDURE), CyberKnife Stereotactic Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT00840749?
This trial is sponsored by Accuray Incorporated, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.